Mark C. McKenna - 17 Jul 2024 Form 4 Insider Report for NewAmsterdam Pharma Co N.V. (NAMS)

Role
Director
Signature
/s/ Louise Kooij by Power of Attorney from Mark C. McKenna
Issuer symbol
NAMS
Transactions as of
17 Jul 2024
Net transactions value
$0
Form type
4
Filing time
19 Jul 2024, 16:31:03 UTC
Previous filing
19 Jul 2024
Next filing
16 Dec 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NAMS Option (right to buy) Award $0 +72,500 $0.000000 72,500 17 Jul 2024 Ordinary Shares 72,500 $18.81 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 33% of the shares underlying the option will vest on July 17, 2025, the one-year anniversay of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for two years, subject to the Reporting Person's continued service through each such date.